Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from diabetes

From Crisis to Possible Cure Path: San Antonio Battles Highest Diabetes Rates as Wegovy and Medicare (United States) Expansion Offer New Hope

Diabetes care is entering a new era in San Antonio as the Wegovy pill and expanded Medicare coverage offer new hope for preventing and managing diabetes in one of America's hardest-hit cities.

Medical Daily

Why insulin, the core element of diabetes treatment remains inaccessible for millions of people

The discovery of insulin in 1921 revolutionised diabetes care. Type 1 diabetes went from being a death sentence to a manageable chronic condition.

The Conversation

ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows

GLASGOW, Scotland, June 4, 2026 /PRNewswire/ -- New findings from the landmark FLOW trial, presented at the 63rd ERA Congress, show that once-weekly semaglutide significantly improved health-related quality of life in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD), equivalent to around eight additional days in full…

AAP

From analysis to the latest developments in health,
read the most diverse news in one place.

MiniMed Group Q4 Earnings Call Highlights

MiniMed Group (NASDAQ:MMED) reported record fiscal 2026 revenue and outlined a slate of product launches it said will support faster growth in fiscal 2027, as management held the company’s first earnings call as a standalone public company following its March IPO. Chief Executive Officer Que Dallar

MarketBeat

Medtronic Q4 Earnings Call Highlights

Medtronic (NYSE:MDT) reported what executives described as its strongest top-line performance in a decade, as growth in cardiac ablation, diabetes, medical-surgical products and select neuroscience platforms helped drive fiscal fourth-quarter and full-year results above expectations. Chairman and C

MarketBeat

Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss

Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordable for diabetes and obesity management. The company is the first in India to offer this convenient format. This move intensifies competition in the growing Indian drug market. Alkem aims to expand access…

The Economic Times

GLP-1 drugs like Ozempic show promise for more than weight loss. But what’s science vs hype?

You’ve probably heard of Ozempic or Wegovy. These are the injectable drugs that have become household names for weight loss and diabetes.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

The supplement your doctor hasn't mentioned yet could be quietly fighting type 2 diabetes - here's everything you need to know

Fish oil benefits for type 2 diabetes: Fish oil supplementation reduced insulin resistance and improved glucose tolerance in non-obese diabetic rats, suggesting inflammation plays a key role even without excess weight. Omega-3 fatty acids shifted immune cells towards an anti-inflammatory state, potentially improving metabolic health.

The Economic Times

Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soon

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabetes, heart disease, and infections. This move aims to reduce treatment costs for millions of patients managing chronic illnesses, with benefits expected to reach consumers within two to three months as new…

The Economic Times

Medicare Drug Savings Surge: 1 in 3 Seniors Now Pays Less Than $35 a Month for Insulin—Here’s How

Nationwide, an estimated 3.5 to 4 million older adults (seniors aged 65 and older) rely on insulin to manage their diabetes. Somewhere around one in...

Saving Advice

MannKind Wins FDA Approval for Afrezza in Children, Opening Pediatric Diabetes Market

MannKind (NASDAQ:MNKD) said the U.S. Food and Drug Administration has approved Afrezza for pediatric patients with diabetes ages 6 and older, expanding the inhaled mealtime insulin’s label into children and adolescents. Chief Executive Officer Michael Castagna called the decision “a truly historic

MarketBeat

India’s GLP-1 Weight Loss Drug Problem Nobody Is Warning You About

A 26-year-old marketing executive in Mumbai loses 14 kilos in three months. Her Instagram fills with compliments. Friends ask for her “secret.” She smiles and says it is just discipline and calorie control. What she does not mention is the weekly injection sitting inside her refrigerator. Across India, GLP-1 drugs…

MyLifeXP

Could GLP-1 Drugs Do More Than Aid Weight Loss? Some Studies Link Them to Lower Tumor Risk

GLP-1 medications already changed the conversation around weight loss, diabetes care, and metabolic health. Now researchers explore an even more intriguing question: could these drugs influence cancer risk as well. Early studies continue to spark interest because they show patterns that go beyond appetite control and blood sugar regulation.

Clever Dude

Don’t Ignore This: Why Professional Primary Care Services Are Essential for Better Health

Many health conditions begin quietly without obvious symptoms. People often assume they are healthy simply because they do not feel sick, but hidden issues such as high blood pressure, diabetes, and heart disease can slowly develop over time.

inkl

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

The medical condition ‘rising twice as fast’ among UK women

IN FULL

Evening Standard

Type 2 diabetes rates ‘rising twice as fast in younger women’

It has been suggested that the figure could be down to ‘little or no follow-up care’ for those who develop the condition while pregnant.

The Independent UK

‘I had gestational diabetes during my pregnancy. Six years later, I’ve yet to receive any follow-up care’

Gestational diabetes usually disappears after birth, although patients face a higher risk of developing type 2 diabetes

The Independent UK

Heatwave warning for millions using insulin, metformin and antidepressants

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning that high temperatures can compromise the effectiveness of medicines and impact how the body responds to them, particularly for individuals managing long-term conditions. Overheating: Many medicines require storage below 25°C, as heat can degrade active ingredients in various…

Get all your
news in one place.

100's of premium titles.
One news app.

AAP

'Game-changing' diabetes treatment approved

Australians living with an early stage of type 1 diabetes can now be treated with the first non-insulin drug saving them years of needles.

MyLifeXP

What Happens to Your Body After 3 Days in 45°C Heat

When the temperature climbs to 45°C, your body enters survival mode. Sweating, increased heart rate, fatigue, headaches, and irritability are not random summer discomforts. They are biological alarms. Most people think heat becomes dangerous only when someone collapses outdoors. But doctors warn that damage often starts much earlier and builds…

Barchart

Are Wall Street Analysts Bullish on Insulet Stock?

Although Insulet has lagged the broader market over the past year, Wall Street analysts remain strongly optimistic about the company’s long-term growth prospects.

Saving Advice

GLP-1s Now Linked To Lower Risk Of 4 Different Cancerous Tumors

What started as a diabetes medication has rapidly become one of the most talked-about drug categories in modern medicine. GLP-1 medications such as Ozempic, Wegovy,...

MyLifeXP

5 People Who Should Never Eat Papaya: Hidden Dangers You Should Know About

Papaya has built a reputation as one of the healthiest fruits in the world. Rich in vitamin C, antioxidants, potassium, and digestive enzymes, it’s often recommended for glowing skin, better digestion, and improved immunity. Whether eaten ripe as breakfast or consumed raw in salads, papaya has become a staple in…

The Independent UK

‘Beef. It’s what’s for dinner’: Previous health risks linked to the red meat debunked

More than 36 million Americans live with Type 2 diabetes

Budget and the Bees

GLP-1 Drugs Could Soon Treat Heart Failure and Peripheral Artery Disease—FDA Approvals Coming

GLP-1 drugs are no longer just weight-loss and diabetes medications. Researchers are now studying whether these blockbuster treatments can help people living with heart failure and peripheral artery disease (PAD), two serious conditions affecting millions of Americans. That shift could reshape how doctors manage cardiovascular disease in the coming years.…

1 2 3 4 5

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.